Monopar Therapeutics Inc.
MNPR
Jodie situation report
Monopar Therapeutics Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 11 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
- MNPR's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if MNPR's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind MNPR
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AZNAstraZeneca PLCpartnerMar 27, 2026 ▾
“We believe that recent financing rounds and the issuance of our common stock to AstraZeneca pursuant to our licensing agreement, along with additional fundraising efforts in the future, may trigger an “ownership change” limitation.”
WBHCFiling-linked namepartnerMay 14, 2026 ▾
“In October 2024, we in-licensed ALXN1840 (tiomolybdate choline) from Alexion, AstraZeneca Rare Disease, and are pursuing regulatory approval and if successful, commercialization of this late-stage drug candidate for Wilson disease.”
BMRNBioMarin Pharmaceutical Inc.investeeAug 12, 2025 ▾
“In aggregate, our team has co-founded BioMarin Pharmaceutical (Nasdaq: BMRN), Sensant Corp.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 6 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MNPR is currently a Follower in the organic co-movement group Building Materials & Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for MNPR; it is not active in the latest market snapshot.